Study of ABCB1 polymorphism frequency in breast cancer patients from Poland

[1]  E. Balcerczak,et al.  Investigation of ABCB1 1236 and 2677 SNPs in patients with peptic ulcer , 2012, Scandinavian journal of gastroenterology.

[2]  E. Balcerczak,et al.  C3435T polymorphism of the ABCB1 gene: impact on genetic susceptibility to peptic ulcers , 2011, Pharmacological reports : PR.

[3]  Jun Wang,et al.  Significant association between ABCB1 gene C3435T polymorphism and breast cancer risk , 2011, Breast Cancer Research and Treatment.

[4]  M. Weinfeld,et al.  Cationic polymer‐mediated small interfering RNA delivery for P‐glycoprotein down‐regulation in tumor cells , 2010, Cancer.

[5]  G. Pasz-Walczak,et al.  ABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer , 2010, International Journal of Colorectal Disease.

[6]  G. Koren,et al.  Placental P-glycoprotein and breast cancer resistance protein: influence of polymorphisms on fetal drug exposure and physiology. , 2010, Placenta.

[7]  J. Kolesar,et al.  Clinical significance of ABCB1 genotyping in oncology , 2010, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[8]  A. Kohút,et al.  MDR1 (C3435T) polymorphism: relation to the risk of breast cancer and therapeutic outcome , 2010, The Pharmacogenomics Journal.

[9]  M. Taheri,et al.  Effect of MDR1 polymorphism on multidrug resistance expression in breast cancer patients. , 2010, Genetics and molecular research : GMR.

[10]  A. León,et al.  Gene polymorphisms in TYMS, MTHFR, p53 and MDR1 as risk factors for breast cancer: a case-control study. , 2009, Oncology reports.

[11]  A. Chandrasekaran,et al.  A single-nucleotide polymorphism in the MDR1 gene as a predictor of response to neoadjuvant chemotherapy in breast cancer. , 2009, Clinical breast cancer.

[12]  Jaejoon Jung,et al.  G-T haplotype (2677G>T/A and 3435C>T) of ABCB1 gene polymorphisms is associated with ethnic differences to paclitaxel sensitivity in cancer cells with different gene expression pattern. , 2009, Cancer letters.

[13]  Michael M Gottesman,et al.  A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function. , 2009, Biochimica et biophysica acta.

[14]  J. Behravan,et al.  Association of C3435T single-nucleotide polymorphism of MDR1 gene with breast cancer in an Iranian population. , 2009, DNA and cell biology.

[15]  A. Ashariati.  Polymorphism C3435T of the MDR-1 gene predict response to preoperative chemotherapy in locally advanced breast cancer with Her2/neu expression. , 2008, Acta medica Indonesiana.

[16]  R. Xavier,et al.  ABCB1 C1236T, G2677T/A and C3435T polymorphisms in systemic lupus erythematosus patients. , 2008, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[17]  A. Yasunaga,et al.  Association of a polymorphism of ABCB1 with obesity in Japanese individuals. , 2008, Genomics.

[18]  M. Hou,et al.  Multiple Genetic Polymorphisms of GSTP1 313AG, MDR1 3435CC, and MTHFR 677CC Highly Correlated with Early Relapse of Breast Cancer Patients in Taiwan , 2008, Annals of Surgical Oncology.

[19]  A. Yaren,et al.  MDR1 C3435T polymorphism in patients with breast cancer. , 2007, Archives of medical research.

[20]  A. Štanclová,et al.  A polymorphism C3435T of the MDR-1 gene associated with smoking or high body mass index increases the risk of sporadic breast cancer in women. , 2007, Oncology reports.

[21]  Marylyn D. Ritchie,et al.  ABCB1 and GST polymorphisms associated with TP53 status in breast cancer , 2007, Pharmacogenetics and genomics.

[22]  Lippincott-Schwartz,et al.  Supporting Online Material Materials and Methods Som Text Figs. S1 to S8 Table S1 Movies S1 to S3 a " Silent " Polymorphism in the Mdr1 Gene Changes Substrate Specificity Corrected 30 November 2007; See Last Page , 2022 .

[23]  Michael R. Johnson,et al.  Clinical factors and ABCB1 polymorphisms in prediction of antiepileptic drug response: a prospective cohort study , 2006, The Lancet Neurology.

[24]  Y. Sanz,et al.  Phytase activity as a novel metabolic feature in Bifidobacterium. , 2005, FEMS microbiology letters.

[25]  M. Droździk,et al.  P-glycoprotein drug transporter MDR1 gene polymorphism in renal transplant patients with and without gingival overgrowth. , 2004, Journal of clinical periodontology.

[26]  R. Kreienberg,et al.  Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer. , 2003, International journal of oncology.

[27]  K. Cowan,et al.  Multiple drug resistance in cancer therapy , 1994, The Medical journal of Australia.

[28]  Jie Yang,et al.  Association between two polymorphisms of ABCB1 and breast cancer risk in the current studies: a meta-analysis , 2010, Breast Cancer Research and Treatment.

[29]  I. Cascorbi,et al.  Pharmacogenetics of ATP-binding cassette transporters and clinical implications. , 2010, Methods in molecular biology.

[30]  J. Roh,et al.  Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  Kazuya Maeda,et al.  Impact of genetic polymorphisms of transporters on the pharmacokinetic, pharmacodynamic and toxicological properties of anionic drugs. , 2008, Drug metabolism and pharmacokinetics.

[32]  M. Droździk,et al.  Frequency of common MDR1 gene variants in a Polish population. , 2006, Pharmacological reports : PR.